SKF-87516J

N/A

Report date: 2023/06/14 09:12:46

Base Information

Drug NameSKF-87516J

Drug Alias NameSKF-87516

ClassificationSmall molecules

Mechanisms of ActionDopamine receptors agonists

TargetsDopamine receptors

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A

Related LinksN/A